192 related articles for article (PubMed ID: 30025229)
1. ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells.
Alessandrini F; Pezzè L; Menendez D; Resnick MA; Ciribilli Y
Neoplasia; 2018 Aug; 20(8):857-870. PubMed ID: 30025229
[TBL] [Abstract][Full Text] [Related]
2. ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes.
Pezzè L; Meškytė EM; Forcato M; Pontalti S; Badowska KA; Rizzotto D; Skvortsova II; Bicciato S; Ciribilli Y
Cell Death Dis; 2021 Jul; 12(8):742. PubMed ID: 34315857
[TBL] [Abstract][Full Text] [Related]
3. ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis.
Meškytė EM; Pezzè L; Bartolomei L; Forcato M; Bocci IA; Bertalot G; Barbareschi M; Oliveira-Ferrer L; Bisio A; Bicciato S; Baltriukienė D; Ciribilli Y
Cell Death Dis; 2023 Apr; 14(4):263. PubMed ID: 37041130
[TBL] [Abstract][Full Text] [Related]
4. ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report.
Sakil HAM; Stantic M; Wolfsberger J; Brage SE; Hansson J; Wilhelm MT
Cell Oncol (Dordr); 2017 Dec; 40(6):631-638. PubMed ID: 28677036
[TBL] [Abstract][Full Text] [Related]
5. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
6. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
Chewchuk S; Guo B; Parissenti AM
PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
[TBL] [Abstract][Full Text] [Related]
7. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells.
Hu Q; Gong JP; Li J; Zhong SL; Chen WX; Zhang JY; Ma TF; Ji H; Lv MM; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2014; 15(13):5137-42. PubMed ID: 25040964
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin.
Alshaer W; Alqudah DA; Wehaibi S; Abuarqoub D; Zihlif M; Hatmal MM; Awidi A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357721
[TBL] [Abstract][Full Text] [Related]
10. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
[TBL] [Abstract][Full Text] [Related]
11. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
[TBL] [Abstract][Full Text] [Related]
12. Chaperoning mitochondrial permeability transition: regulation of transition pore complex by a J-protein, DnaJC15.
Sinha D; D'Silva P
Cell Death Dis; 2014 Mar; 5(3):e1101. PubMed ID: 24603329
[TBL] [Abstract][Full Text] [Related]
13. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
14. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of the ETS Family in Melanoma Reveals a Regulatory Role of ETV7 in the Immune Microenvironment.
Qu H; Zhao H; Zhang X; Liu Y; Li F; Sun L; Song Z
Front Immunol; 2020; 11():612784. PubMed ID: 33424867
[TBL] [Abstract][Full Text] [Related]
17. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
[TBL] [Abstract][Full Text] [Related]
18. HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.
Kang HJ; Yi YW; Hong YB; Kim HJ; Jang YJ; Seong YS; Bae I
Sci Rep; 2014 Dec; 4():7201. PubMed ID: 25467193
[TBL] [Abstract][Full Text] [Related]
19. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
20. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity.
Hermawan A; Wagner E; Roidl A
Oncol Rep; 2016 Mar; 35(3):1732-40. PubMed ID: 26708059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
